Page last updated: 2024-11-12

norsecurinine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

norsecurinine: isolated from Phyllanthus niruri; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
PhyllanthusgenusA plant genus of the family EUPHORBIACEAE. Bahupatra (MEDICINE, AYURVEDIC) is prepared from this.[MeSH]Phyllanthaceae[no description available]

Cross-References

ID SourceID
PubMed CID11106439
SCHEMBL ID20558492
MeSH IDM0143577

Synonyms (17)

Synonym
norsecurinine
(-)-norsecurinine
2650-35-3
nor-securinine
a-norsecurinan-11-one
opf6a516xh ,
unii-opf6a516xh
ent-norsecurinine
SCHEMBL20558492
6,10b-methano-10bh-furo(2,3-c)pyrrolo(1,2-a)azepin-2(6h)-one, 8,9,10,10a-tetrahydro-, (6s-(6.alpha.,10a.beta.,10b.alpha.))-
(6s,10ar,10bs)-8,9,10,10a-tetrahydro-6,10b-methano-10bh-furo(2,3-c)pyrrolo(1,2-a)azepin-2(6h)-one
6,10b-methano-10bh-furo(2,3-c)pyrrolo(1,2-a)azepin-2(6h)-one, 8,9,10,10a-tetrahydro-, (6s,10ar,10bs)-
DTXSID40949368
(1s,8s,13r)-2-oxa-9-azatetracyclo[6.5.1.01,5.09,13]tetradeca-4,6-dien-3-one
6,10b-methano-10bh-furo[2,3-c]pyrrolo[1,2-a]azepin-2(6h)-one, 8,9,10,10a-tetrahydro-, (6s,10ar,10bs)-
6,10b-methano-10bh-furo(2,3-c)pyrrolo(1,2-a)azepin-2(6h)-one, 8,9,10,10a-tetrahydro-, (6s-(6alpha,10abeta,10balpha))-
AKOS040740313
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]